{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-27",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 6
    }
  },
  "results": [
    {
      "update_type": "Reverified",
      "initial_posting_date": "08/03/2022",
      "package_ndc": "0378-4415-01",
      "generic_name": "Flurazepam Hydrochloride Capsule",
      "contact_info": "1-844-874-7464",
      "availability": "Unavailable",
      "related_info": "Anticipated availability: Q4 2026; Delay is due to manufacturing delays at the contract manufacturing facility.",
      "update_date": "08/24/2026",
      "therapeutic_category": [
        "Neurology",
        "Other"
      ],
      "dosage_form": "Capsule",
      "presentation": "Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01)",
      "company_name": "Rising Pharma Holdings, Inc.",
      "shortage_reason": "Regulatory delay",
      "status": "Current"
    }
  ]
}